ONCT Stock Summary and Trading Ideas (Oncternal Therapeutics | NASDAQ:ONCT)

Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. The Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to ROR1 (Receptor-tyrosine kinase-like Orphan Receptor 1), and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoprotein. The Company is also developing ONCT-808, a CAR-T (chimeric antigen receptor T-cells) product candidate that target ROR1, and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The Company has one operating segment in the United States.

Oncternal Therapeutics trades on the NASDAQ stock market under the symbol ONCT.

As of April 23, 2024, ONCT stock price climbed to $8.77 with 955 million shares trading.

ONCT has a beta of 2.51, meaning it tends to be more sensitive to market movements. ONCT has a correlation of 0.08 to the broad based SPY ETF.

ONCT has a market cap of $25.94 million. This is considered a Sub-Micro Cap stock.

Last quarter Oncternal Therapeutics reported $297,000 in Revenue and -$3.11 earnings per share. This beat revenue expectation by $157,000 and missed earnings estimates by -$.04.

In the last 3 years, ONCT stock traded as high as $137.80 and as low as $5.22.

The top ETF exchange traded funds that ONCT belongs to (by Net Assets): VTI, VXF, DFAT, DFAS, DFAC.

ONCT has outperformed the market in the last year with a price return of +33.6% while the SPY ETF gained +24.3%. ONCT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +27.0% and +1.7%, respectively, while the SPY returned +4.6% and -2.6%, respectively.

ONCT support price is $7.88 and resistance is $9.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ONCT stock will trade within this expected range on the day.